Lugano, Switzerland; Denver, CO, USA, 12 March 2021 - The European Lung Cancer Congress 2021, the annual event devoted to advance the quality of lung cancer treatment, will be held as a virtual meeting (25-27 March). (1)
More than 200 studies will be presented (oral or e-poster presentations) and published online as a supplement of the Journal of Thoracic Oncology. (2)
Programme highlights
- New perspectives in the treatment of small cell lung cancer and mesothelioma, including novel agents and prospects for chemotherapy, radiotherapy and immunotherapy
- Lung cancer prevention, with a focus on smoking cessation and the safety and effectiveness of e-cigarettes
- Management and treatment options for both early and advanced stage disease in non-small cell lung cancer
- The role of immunotherapy in the treatment of lung cancer
Keynote lectures
- "Heine H. Hansen Award 2021 lecture: Drop by drop makes a lake - 30 years of progress in lung cancer" by Johan Vansteenkiste, 25 March 2021, 09:15-09:45
- "Heine H. Hansen Award 2020 lecture: Biopsies, biomarkers and biology" by Fiona Blackhall, 26 March 2021, 09:15-09:45
- "Progress and future perspectives of peri-operative therapy of NSCLC" by Tetsuya Mitsudomi, 26 March 2021, 14:35-15:05
Press programme
- More than one in 10 patients with lung cancer do not know what type they have
- Second drug targeting KRASG12C shows benefit in mutated non-small-cell lung cancer
###
Media registration
The ELCC organisers welcome media interested in obtaining information and reporting on cancer issues. Only through the official accreditation process with the media registration form, accredited media representatives will be able to access scientific and educational sessions (live streamed and on-demand), live chat and Q&A, e-posters and chat with poster presenters, virtual exhibition and industry satellite symposia, Congress webcasts, and embargoed material. (3)
For further information
ELCC Press Office
media@esmo.org
References
(1) European Lung Cancer Virtual Congress 2021 https://www.esmo.org/meetings/european-lung-cancer-virtual-congress-2021
(2) Congress programme https://cslide.ctimeetingtech.com/elcc2021_virtual/attendee/confcal/session/calendar
(3) Media Registration Form https://esmo.formstack.com/forms/media_registration_form_elcc_2021
Notes to Editors
Please make sure to use the official name of the meeting in your reports: European Lung Cancer Virtual Congress 2021
Official Congress Hashtag: #ELCC21
About the European Society for Medical Oncology (ESMO)
ESMO is the leading professional organisation for medical oncology. With more than 25,000 members representing oncology professionals from over 160 countries worldwide, ESMO is the society of reference for oncology education and information. ESMO is committed to offer the best care to people with cancer, through fostering integrated cancer care, supporting oncologists in their professional development, and advocating for sustainable cancer care worldwide. http://www.esmo.org
About the International Association for the Study of Lung Cancer (IASLC)
IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes nearly 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit http://www.iaslc.org for more information.
About ELCC
The ELCC Congress brings together some of the most important organisations in the field of thoracic oncology, with the scope of disseminating education through a multidisciplinary approach and improve the practice of lung cancer specialists worldwide. The ELCC Congress is organised by ESMO (European Society for Medical Oncology) and the IASLC (International Association for the Study of Lung Cancer), along with their partner societies ESTRO (European Society for Radiotherapy & Oncology), ESTS (European Society for Throacic Surgeons) and ETOP (European Thoracic Oncology Platform)